Pantomath Capital Welcomes Kamraj Singh Negi to Lead Value Creation in India’s Growth Markets

Mumbai (Maharashtra) [India], August 7:  Pantomath Capital today announced the appointment of Kamraj Singh Negi as MD & CEO (Investment Banking). Kamraj joins from DAM Capital, along with his core team, including Siddharth Shah and Sharad Dhariwal. Notably, all three were part of the senior leadership at DAM Capital prior to this transition. This strategic leadership expansion further strengthens Pantomath Capital’s deep commitment to catalysing the growth of India’s most promising businesses.

Pantomath Capital, part of the Pantomath Group, which houses a large Pre-IPO fund, Mutual Fund, Retail broking and other financial services, is a leading investment bank for mid-market enterprises, with over 150 successfully closed transactions across IPOs, private equity, M&A, and structured solutions. It prides itself in taking companies public that traditional investment banks often overlook—leading high-conviction mandates that contribute to the theme of nation building. As the sole banker in several IPOs, Pantomath Capital has built institutional participation from the ground up, earning a reputation for spotting asset-backed, scalable companies early on — those emerging from Tier 2 & Tier 3 cities and beyond. As an organisation, it has consistently backed growth stories outside traditional metro hubs.

Kamraj brings over two decades of experience in the capital market, M&A, and institutional leadership. He was most recently Managing Director – Investment Banking at DAM Capital, where he led several marquee transactions across sectors. Prior to that, he held senior roles at IDFC Securities, IDFC First Bank, Vodafone Idea, and other established institutions. Well-regarded for his strategic clarity and decisive execution, Kamraj’s transaction expertise spans telecom, media, internet, retail, FMCG, and financial services.

Siddharth and Sharad bring over two decades of investment banking experience each, in leading organisations like Enam Securities, Axis Capital, amongst others, having led large and complex transactions across ECM, M&A, private equity, and strategic advisory. They have advised leading corporates and financial sponsors on both buy-side and sell-side mandates, capital market transactions and long-term capital strategies. Their strong client relationships make them instrumental in managing high-value mandates. Both will take on senior leadership roles at Pantomath Capital as Managing Directors.

Pantomath Capital is a fast-growing institution that truly understands the potential and growth ambitions of companies from Tier 2, Tier 3 cities and beyond — the real builders of Bharat. It stands out as a prominent investment bank in India with entrepreneurial DNA, deep-rooted promoter access, and the proven ability to convert relationships into meaningful capital market outcomes. The volume and quality of transactions at Pantomath Capital are testament to that,” remarked Kamraj Negi, MD & CEO (Investment Banking), Pantomath Capital.

Pantomath Capital stands out for its sharp execution focus and ability to identify scalable businesses ahead of the curve,” said Siddharth Shah, MD (ECM), Pantomath Capital and  Sharad Dhariwal, MD (ECM), Pantomath Capital, in a joint statement. “We are excited to join, and proud to be part of a team that’s redefining what investment banking can mean for Bharat.”

This is not just a leadership hire—it’s a significant step forward in our long-term commitment to scale with quality,” said Mahavir Lunawat, Founder, Pantomath Capital. “With Kamraj, Siddharth, and Sharad joining us, we are bringing in a high-calibre leadership team with a proven track record in capital raise and Advisory. Pantomath Capital already has a strong, execution-led investment banking team with deep sectoral expertise. Backed by a robust and growing pipeline of domestic and cross-border mandates, we are now well-positioned for the next phase of strategic expansion. Our focus remains unwavering — to partner with high-growth companies, champion the Make in India mission, and enable inclusive wealth creation for discerning investors.”

As India’s mid-market opportunity accelerates, Pantomath Capital continues to lead with institutional rigour, strategic depth, and a focused mission—unlocking value where a few are looking, and delivering outcomes that stand apart.

About Pantomath Capital:

Pantomath Capital Advisors Private Limited is the investment banking arm of the Pantomath Group, known for its discovery-led approach to capital formation and deep alignment with founder-driven enterprises. As a SEBI-registered Category I Merchant Banker, the company has built a reputation for precision-led execution across IPOs, QIPs, private placements, and M&A. Pantomath Capital is among the most active and trusted investment banker to mid-market companies. With a sector-agnostic approach backed by proprietary research, regulatory clarity, and capital markets expertise, it plays an active role i India’s public market ecosystem—not just as facilitators, but as long-term capital architects.

About Pantomath Group:

India’s most integrated & fastest growing mid-market financial services group  

Built for Bharat & Beyond

Pantomath Group is a diversified financial institution built on the conviction that capital, when deployed with insight and intent, can shape enduring institutions and catalyse meaningful economic progress. Founded by Mahavir Lunawat and Madhu Lunawat, the Group brings together institutional discipline with entrepreneurial drive. Pantomath has evolved into a full-spectrum capital powerhouse spanning investment banking, asset management, retail and institutional participation, and digital capital infrastructure. Headquartered in Mumbai with pan-India operations and a regulated presence at GIFT City through The Wealth Company, and a growing global footprint across USA, Singapore & UAE.

For more info: www.pantomathgroup.com

If you have any objection to this press release content, kindly contact [email protected] to notify us. We will respond and rectify the situation in the next 24 hours.

Business

Fischer Medical Subsidiary, Time Medical India, Collaborates with Dr. Cherian to Pioneer Next-Generation AI-Enabled MRI System

Mumbai (Maharashtra) [India], November 4: Fischer Medical Ventures Limited (FISCHER | 524743 | INE771F01041), Time Medical International Ventures (I) P LTD, the wholly owned subsidiary of Fischer Medical Ventures Limited, today announced a strategic collaboration with globally acclaimed neurosurgeon, educator, and innovator Dr Iype Cherian. The collaboration’s sole purpose is the development of DRIS–iMRI Medharanya, a […]

Read More
Agartala Business Dr. Saikat Kar innovation Neurotech Startup Science

From Agartala to Global Innovation: How Tripura’s First Neurotech Startup is Bridging Brain Science with Grassroots Impact

Agartala (Tripura) [India], November 4: In a region celebrated for tea gardens and handicrafts rather than technological ambition, a quiet revolution is unfolding. Codonmind Nexus Private Limited, the Northeast’s pioneering neurotechnology startup, is developing brain-computer interface devices and advanced neurological research tools positioned to compete with national players in a market projected to reach USD […]

Read More
Business Harsheep Hortico Limited

Harshdeep Hortico Reports Strong H1 FY26 with Net Profit of INR 5.7 crore

Mumbai (Maharashtra) [India], November 4: Harsheep Hortico Limited (BSE: HARSHDEEP), specializing in the manufacture and export of pots, planters, garden accessories, and outdoor furniture; announced its Unaudited financials for H1 FY26. Key H1 FY25 Financial Highlights Key Financial Highlights (Consolidated) – H1 FY2025-26 Revenue for H1 FY2025–26 was ₹37.84 crore, compared to ₹24.09 crore in […]

Read More